Short answer
Oncology Institute, Inc. (TOI) filed an 8-K current report with the SEC on March 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 2023 earnings results disclosed via press release in Exhibit 99.1.
Oncology Institute, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2023 earnings results disclosed via press release in Exhibit 99.1
- Filing furnished (not filed) under SEC rules: limits legal liability but does not reduce informational significance to investors
- Full financial details (revenue, margins, EPS) contained in Exhibit 99.1; investors should reference that exhibit for key figures
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oncology Institute, Inc. 8-K filings
Get the next TOI 8-K as it lands
Follow TOI for push alerts, or ask the research agent what this filing means.